8-Week Atopic Dermatitis (AD) Treatment Study
NCT03386032
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
65
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis Eczema
Interventions
DRUG:
Investigational OTC Cream
DRUG:
0.05% Desonide
OTHER:
Placebo Cream
Sponsor
Procter and Gamble